TrialGynecologic oncology2017

A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Janet S Rader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.